Navigation Links
When you cough up green or yellow phlegm you need to be prescribed antibiotics, right?
Date:3/24/2011

Prescribing antibiotics for patients with discoloured phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery, a Cardiff University study has found.

Acute cough is one of the common reasons why people visit their GP and accounts for a large proportion of antibiotics prescribed in the community. One of the most common questions asked by GPs to their patients is about their phlegm: "Are you coughing anything up?" or "What colour is your phlegm?"

Clinicians and patients commonly believe that yellow and green phlegm production is associated with a bacterial infection, which is more likely to benefit from antibiotic treatment compared to non-productive cough or cough that produces clear phlegm.

However, in a new study published in the European Respiratory Journal, Professor Chris Butler and his team from Cardiff University's School of Medicine, together with colleagues from 14 European centres present data from an observational study of 3402 adult patients with acute cough presenting for health care in 14 primary care networks.

The research found that patients producing discoloured phlegm are prescribed antibiotics more frequently than those not producing phlegm unlike those producing clear/white phlegm.

Crucially, antibiotic treatment was not associated with greater rate or magnitude of symptoms score resolution among those who produced yellow or green phlegm. Neither was recovery among those feeling generally unwell on its own, or taken together with phlegm production, associated with antibiotic treatment.

Clinicians and patients are therefore likely to both be over interpreting the importance of the colour of phlegm in the decision whether or not to prescribe, or take, antibiotics.

Professor Butler, who led the study said: "One of the exciting things about this research is that our findings from this large, multi-country observational study resonate with findings from randomised trials where benefit from antibiotic treatment in those producing discoloured phlegm has been found to be marginal at best or non-existent.

"Our findings add weight to the message that acute cough in otherwise well adults is a self-limiting condition and antibiotic treatment does not speed recovery to any meaningful extent.

"In fact, antibiotic prescribing in this situation simply unnecessarily exposes people to side effects from antibiotics, undermines future self care, and drives up antibiotic resistance."

A single centre study, using different research methods, by one of Professor Butler's predecessors at Cardiff University came to similar conclusions to this new research. Despite this, non-evidence based practice remains common across the UK.


'/>"/>

Contact: Angela Watkins
WatkinsA6@cardiff.ac.uk
44-029-208-7190
Cardiff University
Source:Eurekalert

Related medicine news :

1. FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds
2. Parents Still Giving Cough, Cold Meds to Kids Under 2: Poll
3. Cough Syrup Might Help With Dosing of Breast Cancer Drug
4. Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen
5. Too Few Adults Vaccinated Against Whooping Cough: CDC
6. Spread of Whooping Cough Raises Concern
7. Commentary suggests alternatives to routine use of OTC cold/cough meds in children
8. New commentary suggests alternatives to routine use of OTC cold/cough meds in children
9. TechWorld Medicals NasalCare Nasal Cleanse Kit Named “Best New Product” at ECRM Cough & Cold and Allergy Conference
10. Conference highlights UC Berkeleys unique approach to green chemistry
11. Going Green May Cut Hospital Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has ... contents of its ginger ale for allegedly containing no ginger. Dr. Pepper produces the ... Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... 21, 2017 , ... West Dermatology is pleased to announce the newest addition ... 2017, Ms. Vu will join West Dermatology’s large network of medical and cosmetic dermatology ... cancer , and more. She graduated from the University of Florida College of Medicine ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... bone marrow cancer that progresses rapidly without treatment. Newly diagnosed patients face intense ... chance of reoccurrence and relapse. With such a challenging diagnosis that requires ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... MINNEAPOLIS , July 5, 2017 Pace Analytical, a company of ... announcing today that they have acquired ESC Lab Sciences, further solidifying their position ... the United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... of ESC Lab Sciences out of Mt Juliet, TN , ...
(Date:7/1/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... be broadcast live over the Internet on Thursday, July 27, ... the quarterly results will be made available at 7:30 a.m. ... The live audio webcast can be accessed via Zimmer Biomet,s ... archived for replay following the conference call. ...
(Date:6/30/2017)... Medical (AVACEN) announced the publication of new research in the peer-reviewed ... AVACEN Treatment Method to significantly reduce the widespread pain ... ... ... 200 to 400 million people worldwide according to The National Fibromyalgia ...
Breaking Medicine Technology: